Chronic Hepatitis C: Pathophysiology and Clinical Issues

Affiliations

Editorial

Maria Lorena Abate et al. Biology (Basel). 2022.

. 2022 Nov 29;11(12):1737.

doi: 10.3390/biology11121737.

Abstract

Globally, it is estimated that 56 [...].

The authors declare no conflict of interest.

1. Polaris Observatory HCV Collaborators Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: A modelling study. Lancet Gastroenterol. Hepatol. 2022;7:396–415. doi: 10.1016/S2468-1253(21)00472-6. - DOI - PubMed
1. Westbrook R.H., Dusheikolow G. Natural history of hepatitis C. J. Hepatol. 2014;61:S58–S68. doi: 10.1016/j.jhep.2014.07.012. - DOI - PubMed
1. Ružić M., Pellicano R., Fabri M., Luzza F., Boccuto L., Brkić S., Abanavoli L. Hepatitis C virus-induced hepatocellular carcinoma: A narrative review. Panminerva Med. 2018;60:185–191. doi: 10.23736/S0031-0808.18.03472-9. - DOI - PubMed
1. Caviglia G.P., Ciruolo M., Olivero A., Carucci P., Rolle E., Rosso C., Abate M.L., Risso A., Ribaldone D.G., Tandoi F., et al. Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma. Cancers. 2020;12:2776. doi: 10.3390/cancers12102776. - DOI - PMC - PubMed
1. Rosso C., Caviglia G.P., Ciruolo M., Ciancio A., Younes R., Olivero A., Giordanino C., Troshina G., Abate M.L., Rizzetto M., et al. Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: A single-center retrospective study. Minerva Med. 2019;110:401–409. doi: 10.23736/S0026-4806.19.06108-1. - DOI - PubMed